🇺🇸 LLY — Eli Lilly and Company

Healthcare Compra
← Volver

Precio actual

1.149,36 USD

Máx. histórico

1.292,65

16 días

Split 2:1 del 16/10/1997

Caída desde máximo

-11,08%

Rango 52 semanas

712,05 – 1.292,65

Variación hoy

-0,88%

Cierre anterior

1.159,60

Rango de hoy

1.138,31 – 1.158,43

Volumen hoy

2.159.931

Información
Nombre completo
Eli Lilly and Company
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
50.000
PER ⓘ
38,61 (puede no estar actualizado)
Dividend yield
0,60% (puede no estar actualizado)
Precio objetivo analistas
1.315,56 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 3 días
Sobre la empresa

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; and BioArctic AB (publ) for new treatment. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Dividendos repartidos Total últimos 12 meses: 6,6900 USD · Yield: 0,58%
Fecha de pago Importe por participación
09/05/1985 0,0500 USD
08/02/1985 0,0500 USD
08/11/1984 0,0500 USD
09/08/1984 0,0453 USD
09/05/1984 0,0453 USD
08/02/1984 0,0453 USD
07/11/1983 0,0453 USD
09/08/1983 0,0453 USD
09/05/1983 0,0406 USD
09/02/1983 0,0406 USD
05/11/1982 0,0406 USD
09/08/1982 0,0406 USD
10/05/1982 0,0406 USD
08/02/1982 0,0406 USD
06/11/1981 0,0359 USD
Splits Registrados en el histórico de precios
Fecha Ratio
16/10/1997 2:1
21/12/1995 2:1
01/05/1989 2:1
30/01/1986 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/06/2013 52,70 52,83 52,15 52,64 +0,29% 1,29% 4.212.600
07/06/2013 52,58 53,06 52,28 52,49 +0,77% 1,48% 4.367.400
06/06/2013 51,89 52,43 51,34 52,09 +0,54% 2,10% 4.976.800
05/06/2013 52,32 52,87 51,76 51,81 -1,31% 2,12% 4.540.700
04/06/2013 53,14 53,42 52,22 52,50 -1,20% 2,26% 4.093.300
03/06/2013 53,08 53,24 52,52 53,14 -0,04% 1,36% 4.173.000
31/05/2013 53,92 54,06 53,15 53,16 -1,70% 1,69% 4.827.100
30/05/2013 53,93 54,62 53,79 54,08 +0,61% 1,54% 4.393.500
29/05/2013 54,24 54,36 53,44 53,75 -1,45% 1,70% 4.201.600
28/05/2013 54,71 55,19 54,32 54,54 +0,74% 1,59% 4.344.000
24/05/2013 54,50 54,50 53,89 54,14 -1,10% 1,12% 4.983.600
23/05/2013 54,67 55,30 54,51 54,74 -0,33% 1,45% 3.953.000
22/05/2013 55,26 56,06 54,66 54,92 -0,40% 2,53% 4.569.300
21/05/2013 55,07 55,43 54,66 55,14 +0,22% 1,40% 4.220.100
20/05/2013 55,90 55,94 54,88 55,02 -1,57% 1,90% 4.242.600
17/05/2013 55,97 56,23 55,35 55,90 -0,07% 1,57% 3.762.700
16/05/2013 56,56 56,56 55,82 55,94 -1,38% 1,31% 3.819.900
15/05/2013 55,92 57,10 55,92 56,72 +1,52% 2,11% 5.386.200
14/05/2013 55,81 56,18 55,71 55,87 -0,73% 0,84% 4.821.500
13/05/2013 54,72 56,31 54,55 56,28 +2,66% 3,22% 18.982.900
10/05/2013 53,97 54,82 53,88 54,82 +0,48% 1,74% 15.278.800
09/05/2013 54,58 54,94 54,35 54,56 +0,07% 1,08% 12.817.600
08/05/2013 54,23 54,78 54,16 54,52 +0,65% 1,14% 5.429.000
07/05/2013 54,52 54,59 53,85 54,17 -0,55% 1,36% 6.318.500
06/05/2013 55,02 55,16 54,30 54,47 -0,95% 1,56% 4.618.300
03/05/2013 55,19 55,19 54,58 54,99 +0,53% 1,11% 3.407.600
02/05/2013 54,32 54,83 54,15 54,70 +0,85% 1,25% 4.060.900
01/05/2013 55,10 55,13 54,15 54,24 -2,06% 1,78% 5.789.900
30/04/2013 55,90 55,90 55,16 55,38 -1,12% 1,32% 4.679.000
29/04/2013 56,59 56,63 55,79 56,01 -0,80% 1,48% 4.852.700